Anti-Aging Supplement Claims End, Monitoring Of Distributors' Regulatory Compliance Begins
This article was originally published in The Rose Sheet
Executive Summary
Telomerase Activation Sciences settles with FTC over unsupported claims its supplement and topical could restore aging immune systems, increase bone density and reverse the effects of aging skin. The company sold its supplement for up $2,200 per month and had at least $56m in sales.
You may also be interested in...
Is 'Moisturol' Up For Grabs? NBC's Faux Nutricosmetic May Be Worth Reconsidering
The "Moisturol" pill that Dateline NBC pitched in 2006 to test the integrity of the infomercial industry – because it "could not possibly work as advertised" – is a lot less outrageous today amid a global nutricosmetics boom. The Rose Sheet considers how the faux beauty-from-within innovation might fare with consumers and regulators in 2017.
NAD Tugs On FTC's Sleeve Again About New Nordic Supplement Claims
New Nordic says it is reformulating its Skin Care Collagen Filler supplement and updating ad claims to more closely reflect its testing, but NAD says the firm is not complying with its recommendations. NAD refers New Nordic claims to FTC for the second time in six months.
IFF Narrows Focus To Fragrance, Health, Food
International Flavors & Fragrances agrees to sell its Pharma Solutions business to plant-based ingredients company Roquette for an enterprise value of $2.85bn to reduce debt and streamline its business to three segments, including scents.